


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+4.61%
+0.08%
-8.89%
+0.11%
+0.02%
ITRI
Itron
$95.92
Strengths

Earnings are forecast to grow

Investors confidence is positive
ITRI Price Performance
$98.56 (-2.68%)
$124.56 (-22.99%)
$125.75 (-23.72%)
$103.61 (-7.42%)
ITRI has Fair risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

ITRI overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a weak earnings
Rating
Rating
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Investors confidence is positive
Future
Future

Earnings are forecast to grow
![]()
ITRI Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
ITRI Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels
What is ITRI current stock price?
What are ITRI stock strengths?
What is ITRI Risk Level?
What is ITRI market cap and volume?
What is ITRI current Stock IQ?
Should I buy ITRI stock right now?
Is ITRI a Strong Buy right now?
What does a 'Strong Buy' rating mean for ITRI?
What does a 'Strong Sell' rating mean for ITRI?
What factors influence ITRI's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+4.61%
+0.08%
-8.89%
+0.11%
+0.02%
ITRI
Itron
Current Price
$95.92
Stock Insights
Strengths

Earnings are forecast to grow

Investors confidence is positive

ITRI Price Performance
$98.56 (-2.68%)
$124.56 (-22.99%)
$125.75 (-23.72%)
$103.61 (-7.42%)
ITRI Analysts Opinion
ITRI Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a weak earnings
Rating
Rating
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Investors confidence is positive
Future
Future

Earnings are forecast to grow
![]()
ITRI Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
ITRI Street Sentiment is extremely bullish and have positive views on the near-term outlook
ITRI has Fair risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Average key support and resistance price levels
ITRI Stock IQ
ITRI Latest Analysis
Churchill Capital Corp X (CCCX) Stock Is Rallying Today: Whats Driving The Christmas Cheer?. ) shares are trading higher on Wednesday. Citron Research made ish commentary earlier this week as quantum computing stocks are experiencing a broad wave of momentum.Churchill Capital stock is among today’.s top performers. on its merger partner Citron suggested Churchill'.s market cap could overtake
Wed Dec 24, 2025
Citrons Andrew Left Says This Quantum Stock Is Real And Set To Pop In 2026 As Similar Companies Soar Amid Santa Rally. Citron Research led by On Monday in a post on X Left reiterated his ish stance on ) a neutral atom quantum technology company citing its collaboration with French aeronautics giant Left said Infleqtion which went earlier this year is “.no longer a science project”. signaling a shift from experimental development to what he views as a commercially viable phase. “.
Tue Dec 23, 2025
RADX: Interim Readout Achieves 92% Concordance. By RAD101 Phase IIb Interim AnalysisRadiopharm Theranostics (NASDAQ:RADX) the primary endpoint for its RAD101 trial in an interim analysis on December 15th. Following the release management held a which featured the companys CEO Riccardo Canevari Chief Medical Officer Dr. Dimitris Voliotis and the principal investigator on the RAD101 trial Dr. Harshad Kulkarni.Topline from the release indicated that 92% (11/12) of evaluated patients treated with R
Mon Dec 22, 2025
Kitron ASA: Receipt of regulatory approvals related to the acquisition of DeltaNordic. Company) on 19 November 2025 regarding the entering into agreement to through its subsidiary Kitron Holding AB acquire DeltaNordic AB (the Transaction).
Mon Dec 22, 2025
Kitron signs €7M agreement with new customer within autonomous systems for the defence industry. (2025-12-22) Kitron has signed an agreement with a new customer for an estimated value of EUR 7 million for the production and supply of advanced electronics for autonomous systems across air land and sea domains for the defense industry.
Mon Dec 22, 2025
Kitron receives order valued at EUR 44 million driven by rising demand for Data center electrification. (2025-12-18) Kitron has received an order valued at EUR 44 million for the production and supply of advanced electronic components used in energy storage and electric grid balancing systems. The order is closely linked to increasing demand from the fast-growing data center segment where large-scale electrification resilience and power-balancing capabilities have become critical.
Thu Dec 18, 2025
This Fund Just Dumped Itron Stock but Should Long-Term Investors Follow Suit?. Key PointsAristotle Capital Boston sold 123119 shares of Itron in the third quarter.
Tue Dec 16, 2025
Itron (ITRI) is a Top-Ranked Growth Stock: Should You Buy?. The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why you should take advantage.
Mon Dec 15, 2025
Kitron secures EUR 17 million contract for combat vehicle components. (2025-12-11) Kitron has received a contract with an estimated value of EUR 17 million for the production and supply of advanced electronic components used in combat vehicle systems.Deliveries under the contract are scheduled to start in the second half of 2026 and production will take place at a European Kitron facility.We are proud to strengthen our role as a trusted manufacturing partner in the ...
Thu Dec 11, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
ITRI Stock trends
ITRI Stock performance
ITRI Stock analysis
ITRI investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.